According to The Insight Partners –The global tissue engineering market is on a robust growth trajectory, projected to rise from approximately US$ 13.24 billion in 2022 to US$ 29.66 billion by 2028, expanding at a compound annual growth rate (CAGR) of 12.2% during the forecast period. This remarkable expansion reflects the growing demand for advanced regenerative medicine solutions across a wide array of medical conditions.
What Is Tissue Engineering?
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, material methods, and appropriate biochemical and physicochemical factors to regenerate, preserve, enhance, or replace various types of biological tissues. At its core, it bridges fundamental knowledge in physics, chemistry, and biology to develop practical clinical strategies. The field holds promise across several domains — from repairing bone and cartilage to regenerating heart and pancreatic tissue, and even advancing the study of stem cells, which can develop into many different cell types to help repair the body.
Key Market Drivers
One of the most significant factors fueling market growth is the rising burden of chronic diseases and trauma. According to the WHO, approximately 20–50 million people get injured every year in road accidents. These injuries often affect bones and vital organs, driving demand for tissue engineering as an alternative to conventional surgical reconstruction and transplantation.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00006702
Spinal cord injuries represent another major area of concern. An estimated 3 million people live with traumatic spinal cord injury worldwide, with approximately 180,000 new cases reported each year, many resulting in long-lasting neurological deficits. Tissue engineering, combining cells, scaffolds, and growth factors, is emerging as a promising avenue for addressing such devastating conditions.
Cancer also plays a defining role in market expansion. According to the WHO, approximately 9.6 million deaths occurred due to cancer globally in 2018. The rise of gene and cell therapies such as Novartis’s Kymriah for diffuse large B-cell lymphoma — is creating new avenues for tissue engineering solutions in oncology.
Segmentation Insights
The market is segmented by material type and application. The biologically derived materials segment dominated the market, holding the largest share of 52.54% in 2022, owing to its pivotal role in creating neo-tissues that closely replicate natural body structures and enabling controlled release of chemokines at injury sites. Meanwhile, the synthetic materials segment is expected to register the highest CAGR going forward, driven by advances in biomaterial engineering.
On the application side, the orthopedic, musculoskeletal, and spine segment led the market with a 34.31% share in 2022. However, the skin and integumentary segment is anticipated to record the fastest growth over the forecast period, fueled by demand for advanced wound care and burn treatment solutions.
COVID-19 Impact and Recovery
The COVID-19 pandemic disrupted clinical trials, drug development, and routine tissue engineering research activities globally. However, the post-vaccine period has brought renewed momentum. The US FDA’s approval of plasma therapy for critically ill COVID-19 patients opened new opportunities in the field, and research into stem cells, regenerative medicine, and related therapies has steadily resumed.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00006702
Competitive Landscape
The tissue engineering market is served by several prominent players, including Stryker Corporation, Organogenesis Inc., Cook Biotech Inc., Integra LifeSciences Corporation, 3M, AbbVie Inc., Medtronic, Zimmer Biomet, Baxter International Inc., DePuy Synthes, and B. Braun Melsungen AG. These companies are actively pursuing product launches and geographic expansion to capture a larger share of the growing market.
Outlook
With increasing R&D investment, a growing geriatric population, and accelerating technological advances in areas such as 3D bioprinting and regenerative medicine, the tissue engineering market is poised for sustained, long-term growth well into the next decade.
Top Trending Reports @
White Biotechnology Market Size, Share, Growth and Trends by Forecast by 2031
Agricultural Biotechnology Market Dynamics, Growth, and Opportunities 2031
Biotechnology Market Growth and Analysis by 2031
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
